Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials.
Thomas J ReillyPhoebe WallmanIvana ClarkClare-Louise KnoxMichael C CraigDavid M TaylorPublished in: Journal of psychopharmacology (Oxford, England) (2022)
Since intermittent dosing avoids the potential for withdrawal symptoms, it should be considered more commonly in this patient population.